VolitionRx Chief Medical Officer Dr. Jason Terrell resigns effective Nov 18, 2022

VOLITIONRX LTD

Dr. Jason Terrell resigned as Chief Medical Officer on November 22, 2022, effective retroactively to November 18, 2022.
Company thanked Dr. Terrell for his contributions and wished him success.
No replacement for the CMO position was announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Jason Terrell

Chief Medical Officer

VNRX · VOLITIONRX LTD

Effective: 2022-11-18
Filed: November 25, 2022, 6:59 PM ET

On November 22, 2022, Dr. Jason Terrell tendered written notice to VolitionRx Limited (the “Company”) of his resignation as Chief Medical Officer of the Company, effective as of November 18, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Jason Terrell resigned as Chief Medical Officer at VOLITIONRX LTD.

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On November 22, 2022, Dr. Jason Terrell tendered written notice to VolitionRx Limited (the “Company”) of his resignation as Chief Medical Officer of the Company, effective as of November 18, 2022.

View on SEC.gov

VOLITIONRX LTD filing history →

Source: SEC EDGAR

accession 0001477932-22-008884

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.